glp 1 inflammation Central glucagon-like peptide receptor activation inhibits Toll-like receptor agonist-induced inflammation: Cell Metabolism GLP-1 Drugs: For Multiple Chronic

Why Should We Care

Q: Why are so many doctors pushing GLP1

In 2022, some of the top-selling drugs in this category were Novos Ozempic (US$ 8.7 billion), Lilly and partner Dainippon Sumitomos Trulicity (US$ 7.7 billion), Novos Victoza (US$ 1.8 billion), and Rybelsus (US$ 1.6 billion)

Oboza P, Ogarek N, Olszanecka-Glinianowicz M, Kocelak P

This suppression of appetite helps decrease food consumption and weight gain

Of the 7 included studies, 3 focused on elective surgical procedures, and 4 examined elective EGD (with 1 study also including colonoscopy performed in conjunction with EGD and another study also including lower endoscopy, as shown in Table 2)